|

Nuvastatic 300 Clinical Trials

2 actively recruiting trials

Pipeline

Phase 3: 2

Top Sponsors

  • Natureceuticals Sdn Bhd2

Indications

Other2 trials

A Randomized, Double-blind, Placebo-controlled, Parallel-group, Comparative, Phase III Study to Evaluate the Efficacy and Safety of Nuvastatic® 300mg Capsule in Reducing Cancer-Tumor in Patients With Metastatic Colorectal Cancer Receiving Standard Chemotherapy.
Phase 3
Nuvastatic® Phase III Trial for Fatigue in Triple-Negative Breast Cancer
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.